Computers in Biology and Medicine,
Год журнала:
2022,
Номер
149, С. 105969 - 105969
Опубликована: Авг. 17, 2022
Epidemiological
studies
show
that
COVID-19
variants-of-concern,
like
Delta
and
Omicron,
pose
different
risks
for
severe
disease,
but
they
typically
lack
sequence-level
information
the
virus.
Studies
which
do
obtain
viral
genome
sequences
are
generally
limited
in
time,
location,
population
scope.
Retrospective
meta-analyses
require
time-consuming
data
extraction
from
heterogeneous
formats
to
publicly
available
reports.
Fortuitously,
a
subset
of
GISAID,
global
SARS-CoV-2
sequence
repository,
includes
"patient
status"
metadata
can
indicate
whether
record
is
associated
with
mild
or
disease.
While
GISAID
lacks
on
comorbidities
relevant
severity,
such
as
obesity
chronic
it
does
include
age
sex
use
additional
attributes
modeling.
With
these
caveats,
previous
efforts
have
demonstrated
genotype-patient
status
models
be
fit
data,
particularly
when
country-of-origin
used
an
feature.
But
robust
biologically
meaningful?
This
paper
shows
that,
fact,
temporal
geographic
biases
submitted
well
evolving
pandemic
response,
reduction
disease
due
vaccination,
create
complex
issues
model
development
interpretation.
poses
potential
solution:
efficient
mixed
effects
machine
learning
using
GPBoost,
treating
country
random
effect
group.
Training
validation
temporally
split
emerging
Omicron
variants
demonstrates
GPBoost
more
predictive
impact
spike
protein
mutations
patient
outcomes
than
fixed
XGBoost,
LightGBM,
forests,
elastic
net
logistic
regression
models.
The
continued
evolution
of
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
requires
persistent
monitoring
its
subvariants.
Omicron
subvariants
are
responsible
for
the
vast
majority
SARS-CoV-2
infections
worldwide,
with
XBB
and
BA.2.86
sublineages
representing
more
than
90%
circulating
strains
as
January
2024.
To
better
understand
parameters
involved
in
viral
transmission,
we
characterized
functional
properties
Spike
glycoproteins
from
BA.2.75,
CH.1.1,
DV.7.1,
BA.4/5,
BQ.1.1,
XBB,
XBB.1,
XBB.1.16,
XBB.1.5,
FD.1.1,
EG.5.1,
HK.3,
JN.1.
We
tested
their
capacity
to
evade
plasma-mediated
recognition
neutralization,
binding
angiotensin-converting
enzyme
(ACE2),
susceptibility
cold
inactivation,
processing,
well
impact
temperature
on
Spike-ACE2
interaction.
found
that
compared
early
wild-type
(D614G)
strain,
most
subvariants'
evolved
escape
neutralization
by
plasma
individuals
who
received
a
fifth
dose
bivalent
(BA.1
or
BA.4/5)
mRNA
vaccine
improve
ACE2
binding,
particularly
at
low
temperatures.
Moreover,
had
best
affinity
all
temperatures
tested.
processing
is
associated
inactivation.
Intriguingly,
was
significantly
growth
rates
humans.
Overall,
report
Spikes
newly
emerged
relatively
stable
resistant
present
improved
which
associated,
temperatures,
rates.IMPORTANCEThe
gave
rise
wide
range
variants
harboring
new
mutations
glycoproteins.
Several
factors
have
been
transmission
fitness
such
plasma-neutralization
whether
additional
could
be
importance
variants'
characterize
several
glycoprotein
presents
an
further
temperature.
interaction
strongly
rate,
such,
represent
another
parameter
affecting
transmission.
SSRN Electronic Journal,
Год журнала:
2022,
Номер
unknown
Опубликована: Янв. 1, 2022
Background:
Estimates
of
immunity
and
severity
for
the
SARS-CoV-2
omicron
subvariant
BA.5
are
important
to
assess
public
health
impact
associated
with
its
rapid
global
spread
despite
vaccination.
We
estimated
natural
vaccine
relative
BA.2
in
Denmark,
a
country
high
mRNA
vaccination
coverage
free-of-charge
RT-PCR
testing.Methods:
This
was
an
observational
cohort
study
including
residents
18
years
or
older
test
between
10
April
20
June,
2022,
identified
national
COVID-19
surveillance
system
database
information
since
February,
2020,
on
tests,
wholegenome
sequencing,
vaccinations
hospitalisations
positive
as
main
diagnosis.
calculated
effect
prior
infection
odds
ratio
(OR)
among
triple-vaccinated
individuals
(%protection=1-OR).
For
we
also
OR
triple-vaccination
vs
none
(ie.
effectiveness)
hospitalisation.
ORs
were
logistic
regression
models
adjusted
age,
time,
sex,
region,
comorbidities.Findings:
Among
4,809
cases
164,369
test-negative
individuals,
highly
protective
against
(93.6%,
95%CI92.1-94.8;
96
29,832
omicron).
4,913
31,874
cases,
not
different
(OR1.02,
95%CI0.83-1.26).
Although
overall
number
due
diagnosis
low
stable
during
period,
proportion
infected
increased.
In
crude
analysis
hospitalisation
(OR
1.04
(0.83-1.31)
whereas
1.65
(1.16-2.34).
The
increased
strata
age
calendar
period
–
two
covariates
largest
contribution
confounding
OR.Interpretation:
found
protection
from
similar
effectiveness
currently
BA.2.
covariates,
risk
which
needs
confirmation
continued
period.Funding
Statement:
None.Declaration
Interests:
None.Ethics
Approval
performed
under
authority
task
Danish
infectious
disease
control
institute,
allows
Statens
Serum
Institut
perform
analyses
data
existing
systems.
According
law,
ethical
approval
individual
consent
is
required
anonymized
aggregated
register-based
studies.
Abstract
Background
The
emergence
of
SARS-CoV-2
Omicron
subvariants
has
raised
questions
regarding
resistance
to
immunity
by
natural
infection
or
immunization.
We
examined
the
sensitivity
Delta
and
(BA.1,
BA.1.1,
BA.2,
BA.2.12.1,
BA.4/5,
BA.3)
neutralizing
antibodies
from
BBIBP-CorV-vaccinated
BBIBP-CorV-
ZF2001-boosted
individuals,
as
well
individuals
with
BA.1
breakthrough
infections,
determined
their
fusogenicity
infectivity.
Methods
In
this
cross-sectional
study,
serum
samples
two
doses
1
(
n
=
36),
3
7
37)
months
after
second
dose;
25)
30)
individuals;
fully
vaccinated
26)
were
collected.
serum-neutralizing
reactivity
potency
bebtelovimab
assessed
against
D614G,
Delta,
through
a
pseudovirus
neutralization
assay.
infectivity
cell-cell
fusion
assay
assay,
respectively.
Results
markedly
escaped
vaccine-elicited
BBIBP-CorV
comparable
efficiency.
A
third
dose
vaccination
ZF2001
increased
antibody
titers
breadth
three
subvariants.
infections
induced
D614G
variants,
whereas
elicited
stronger
broader
response
than
infections.
BA.2.12.1
BA.4/5
are
more
resistant
Bebtelovimab
had
no
significant
loss
Cell
culture
experiments
showed
be
less
fusogenic
have
higher
Conclusions
These
findings
important
public
health
implications
highlight
importance
repeated
exposure
antigens
broaden
Applied Artificial Intelligence,
Год журнала:
2025,
Номер
39(1)
Опубликована: Март 14, 2025
Viruses
are
prone
to
rapid
mutations
that
enhance
traits
like
transmissibility
and
resistance
treatments.
The
adaptability
complicates
the
development
of
effective
vaccines.
study
investigates
dynamic
interactions
between
humans
COVID-19
virus
through
time-series
analysis,
focusing
on
how
these
evolve
over
time.
A
novel
approach
was
introduced
using
adversarial
networks
model
relationship
human
viral
entities,
capturing
their
temporal
dynamics.
Two
interdependent
models
trained
within
a
framework,
allowing
us
forecast
identify
influential
features.
Saliency
maps
were
utilized
visualize
factors
affecting
technique
helps
reveal
specific
properties
shift
in
response
factors.
findings
aim
understanding
human-virus
dynamics,
particularly
for
COVID-19,
offering
potential
insights
public
health
strategies
interventions.
By
combining
with
saliency
visualization,
provides
an
intensive
analyzing
interpreting
complex
viruses.
Future Virology,
Год журнала:
2023,
Номер
18(4), С. 225 - 242
Опубликована: Март 1, 2023
Aim:
Bioinformatic
analysis
of
mutation
sets
in
receptor-binding
domain
(RBD)
currently
and
previously
circulating
SARS-CoV-2
variants
concern
(VOCs)
interest
(VOIs)
to
assess
their
ability
bind
the
ACE2
receptor.
Methods:In
silico
sequence
structure-oriented
approaches
were
used
evaluate
impact
single
multiple
mutations.
Results:
Mutations
detected
VOCs
VOIs
led
reduction
binding
free
energy
RBD-ACE2
complex,
forming
additional
chemical
bonds
with
ACE2,
an
increase
complex
stability.
Conclusion:
Mutation
characteristic
have
effects
on
affinity
associated
amino
acid
interactions
at
sites,
as
well
acquisition
other
viral
adaptive
advantages.The
infectious
potential
(Alpha,
Beta,
Gamma,
Delta,
Omicron,
etc.)
that
causes
COVID-19
is
mainly
due
virus
Particularly
important
for
development
disease
interaction
coronavirus
spike
protein
a
receptor
surface
human
cell,
result
which
penetrates
cell.
Angiotensin-binding
enzyme
(ACE2)
such
humans,
there
protein.
In
this
study,
using
bioinformatic
methods,
mutations
RBD
was
carried
out
find
influence
functionality
interact
high
stability,
ultimately
leads
infection.
A
number
virus.
More
recent
more
than
one
RBD,
so
are
complex.
It
constantly
evolving,
increasing
receptor,
avoiding
immune
response.
The
Omicron
variant,
has
least
15
most
successful
these
directions.
iScience,
Год журнала:
2023,
Номер
26(11), С. 108299 - 108299
Опубликована: Окт. 27, 2023
Additional
mutations
in
the
viral
Spike
protein
helped
BA.2.12.1
and
BA.4/5
SARS-CoV-2
Omicron
subvariants
to
outcompete
parental
BA.2
subvariant.
Here,
we
determined
functional
impact
of
that
newly
emerged
(L452Q,
S704L)
(Δ69-70,
L452R,
F486V,
R493Q)
proteins.
Our
results
show
mutation
L452Q/R
or
F486V
typically
increases
R493Q
S704L
impair
Spike-mediated
infection.
In
combination,
changes
Δ69-70,
contribute
higher
infectiousness
fusogenicity
Spike.
L452R/Q
are
mainly
responsible
for
reduced
sensitivity
neutralizing
antibodies.
However,
combined
required
full
infectivity,
TMPRSS2
dependency,
immune
escape
Thus,
it
is
specific
combination
allows
increased
functionality
evasion,
which
helps
explain
temporary
dominance
pathogenicity
these
subvariants.